Recap: Regeneron Pharmaceuticals Q4 Earnings

Regeneron Pharmaceuticals REGN reported its Q4 earnings results on Friday, February 4, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.

Check out this: Insiders Buying Charter Communications And 3 More Stocks

Earnings

Regeneron Pharmaceuticals beat estimated earnings by 30.98%, reporting an EPS of $23.72 versus an estimate of $18.11, which surprised analysts.

Revenue was up $2.53 billion from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $5.88, which was followed by a 5.57% drop in the share price the next day.

Here's a look at Regeneron Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.